Why is "Qntm" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-21 15:25:58
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Sam Hughes, known online as and publishing under the pen name qntm, is a British programmer and science fiction author. Hughes' short stories include "Lena", about the first digital snapshot of a human brain. His serial novels include Ra and Fine Structure. He has also written for the SCP Foundation wiki. His book There Is No Antimemetics Division began as an entry on the wiki. In 2024, Del Rey Books acquired UK and Commonwealth rights to the book, while Ballantine Books acquired the US rights.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
QNTM Jumps 10% Amid Low Trading Volume, Approaches Major Resistance Lacking Strong Momentum - Bitget
-
The Acton Boxborough Beacon Events - qntm.e: BOCHELLA at The Middle East - Wicked Local
-
Why Did QNTM Stock Pop In Pre-Market Today? - Stocktwits
-
If You Invested $1,000 in Quantum BioPharma Ltd (QNTM) - Stock Titan
-
qntm's debut is mind-bending SF that confronts one of our most existential fears - The Bookseller
-
Review | Horror oozes out of the internet in this inventively creepy novel - The Washington Post
-
QNTM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
-
Quantum BioPharma pushes MS drug toward Phase 2 with FDA filing - Stock Titan
-
New MS treatment targeting demyelination moves toward Phase 2 - Stock Titan
-
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC Filing - Form 6-K - Stock Titan
-
Quantum BioPharma (QNTM) advances Lucid-MS plan, details unbuzzd™ royalties and tax assets - Stock Titan
-
Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial - Stock Titan
-
Quantum BioPharma (QNTM) lines up Allucent for Lucid-MS Phase 2 trial - Stock Titan
-
After drinking, this supplement cut headache severity 67% in trial - Stock Titan
-
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC Filing - Form 6-K - Stock Titan
-
Quantum BioPharma (Nasdaq: QNTM) outlines 2025 drug-development and IP risks - Stock Titan
-
Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status - Stock Titan
-
Peer-reviewed Unbuzzd trial backs Quantum BioPharma (QNTM) royalty stream - Stock Titan
-
Quantum BioPharma (QNTM) Soars 33.5% in 2 Hours — What's Driving This Sudden Surge? - Bitget
-
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied - Stock Titan
-
Quantum BioPharma Ltd. Revises Terms of Debenture Units Following Market Price Decrease | QNTM Stock News - Quiver Quantitative
-
Quantum ETF | QNTM - VanEck
-
Quantum BioPharma (QNTM) Soars 22.05% in Intraday Surge: What’s Fueling This Volatility? - Bitget
-
Quantum Biopharma Ltd. (QNTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM - PR Newswire
-
Quantum BioPharma Ltd. to Release Financial Results and Announce Private Placement Offering | QNTM Stock News - Quiver Quantitative
-
Win a Copy of There Is No Antimemetics Division by QNTM in our Penguin Random House Giveaway - Den of Geek
-
Review | 3 utterly brilliant science fiction novels - The Washington Post
-
MS drug program taps veteran neurologist for planned Phase 2 study - Stock Titan
-
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - ChartMill
-
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied - ChartMill
-
VanEck Quantum Computing UCITS ETF A USD Acc (QNTM.L) holdings - Yahoo Finance UK
-
Quantum BioPharma (QNTM) Offers $7M for Solid Evidence of Stock Manipulation - GuruFocus
-
Market Movers | Winners: ACXP, SAFX, SXTP | Losers: CODX, QNTM, KITT - Trefis
-
QNTM Stock Fund Price and Chart — EURONEXT:QNTM - TradingView
-
Quantum BioPharma (NASDAQ: QNTM) ends $21,225,000 ATM, settles $260,000 debt - Stock Titan
-
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC - Stock Titan
-
450+ Published Research Papers: Leading MS Expert Dr. Jack Antel Joins Quantum BioPharma's Clinical Team - Stock Titan
-
Is Quantum BioPharma (CSE:QNTM) Using Too Much Debt? - simplywall.st
-
QNTM ETF Holdings List — EURONEXT:QNTM - TradingView
-
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock - GlobeNewswire
-
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
-
The Guardian’s Best Science Fiction Books of 2025 #SciFiSunday - Adafruit
-
Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend - GlobeNewswire
-
The best recent science fiction, fantasy and horror – review roundup - The Guardian
-
Best Gyms in Nashville - Nashville Guru
-
Quantum BioPharma Makes Strategic Investment in GameStop Corp. - GlobeNewswire
-
Remember, There Is No Antimemetics Division - opus.ing
-
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
-
Discount basketball yeezy raffle chicago Sale adidas YZY QNTM Chicago Store List SneakerNews - маяк32.рф
-
Quantum BioPharma Receives Final Reports for Two Key - GlobeNewswire
-
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
-
There Is No Antimemetics Division by Qntm - Publishers Weekly
-
VanEck launches Europe’s first quantum computing ETF - ETF Stream
-
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial - GlobeNewswire
-
Health Canada Grants Quantum BioPharma a Product License - GlobeNewswire
-
Quantum Biopharma (QNTM) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
-
Quantum BioPharma Announces Intention to Declare Special - GlobeNewswire
-
Kingswood Capital Partners Initiates Analyst Coverage on - GlobeNewswire
-
There Is No Antimemetics Division is a very modern novel that draws from a long literary and pop-culture legacy - thecurb.com.au
-
Qntm entanglement - 24 Dec 2025 - EDGE Magazine - Readly | All magazines - one magazine app subscription
-
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches - GlobeNewswire
-
QNTM Stock Price, News & Analysis | Quantum BioPharma - Stock Titan
-
Latest QNTM News - Quantum BioPharma Wins Significant Court Ch... - Stock Titan
-
symbol__ Stock Quote Price and Forecast - CNN
-
QNTM Stock Price and Chart — CSE:QNTM - TradingView
-
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - newswire.com
-
Should I buy QUANTUM BIOPHAR (QNTM) - Zacks Investment Research
-
QNTM Labs Announces EU-GMP Certified Expansion to Meet Growing Industry Needs - PR Newswire
-
Del Rey snaps up high concept sci-fi cosmic horror from Sam Hughes - The Bookseller
-
This adidas Yeezy QNTM Comes In Hi-Res Coral - Sole Retriever
-
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM" - TMX Newsfile
-
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM" - Stock Titan
-
16-Story Hotel Proposed Next To Popular Fitness Center In The Nashville Gulch. - CITY NOW NEXT
-
The adidas Yeezy QNTM "Quantum" Returns This Week - Nice Kicks
-
The adidas Yeezy QNTM Hi-Res Orange Releases In August - Sole Retriever
-
QNTM Labs - Forbes
-
Quantum BioPharma Expands Global Reach with Upstream Dual Listing, Targets 24/7 Trading Access - Stock Titan
-
adidas Yeezy QNTM - WearTesters
-
Official Images of The adidas Yeezy QNTM Cream - Sole Retriever
-
QNTM Fit Life - Nashville Scene
-
QNTM Forecast — Price Target — Prediction for 2027 - TradingView
-
Former Nashville gym manager who took photos of clients undressing sentenced to jail time - News Channel 5 Nashville
-
Chicago ‘YZY QNTM’ giveaway draws hundreds, creates chaos - The Columbia Chronicle
-
YEEZY QNTM BSKTBL Frozen Blue - WearTesters
-
Kanye West's adidas YEEZY QNTM Appears in New “Flaora” Colorway - hypebeast.com
-
Former QNTM gym manager accused of taking, stealing intimate photos of female clients - News Channel 5 Nashville
-
Quantum Biopharma Ltd. Subordinate Voting Shares Class B Trade Ideas — BOATS:QNTM - TradingView
-
Quable joins Ibexa and QNTM Group, expanding MarTech capabilities and strengthening DXP leadership in Europe - Mynewsdesk
-
Lawsuit filed against QNTM Fit Life Gym in downtown Nashville after trainer's arrest - The Tennessean
-
Kanye West Previews Another Colorway of the New YZY QNTM - Highsnobiety
-
Kanye West's adidas YEEZY QNTM "Amber Tint" Is Officially Releasing Next Month - hypebeast.com
-
QNTM ACQUIRES SAAS COMPANY IBEXA - Mynewsdesk
-
Oakley Launching New Sunglasses At Olympics As Brands Showcase Tech - Forbes
-
adidas YEEZY QNTM "Teal Blue" Will Be Dropping Soon - Hypebae
-
QNTM ACQUIRES QUALIFIO, LEADING EUROPEAN DATA COLLECTION PLATFORM - Mynewsdesk
-
QNTM Group Welcomes Max Sihvonen as Group CCO - Mynewsdesk
-
QNTM Group signs Jo Jemblie Leknes-Monssen as new CFO. - Mynewsdesk
-
adidas YEEZY QNTM "Barium" Officially Releases This Week - SoleSavy
-
A New adidas YEEZY QNTM Looks to be on the Way - Nice Kicks
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.